Hypofractionated stereotactic radiotherapy (hfSRT) after tumour resection of a single brain metastasis: report of a single-centre individualized treatment approach

Journal of Cancer Research & Clinical Oncology, 05/10/2012

Postoperative hypofractionated stereotactic radiotherapy (hfSRT) appears to be a feasible treatment option in patients with a single newly diagnosed brain metastasis. Replacing the standard postoperative whole–brain radiotherapy necessitates compliant patients and regular MRI follow–up analysis.

Print Article Summary Cat 2 CME Report